China MOH and Sanofi Pasteur Collaborations in Pandemic Preparedness. Presented by

Similar documents
Creating VaCCines, ProteCting Life

FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases

GAVI Alliance Demand-side Innovation Policies

STATEMENT OF LYNN STRATFORD SENIOR VICE PRESIDENT, PROGRAM AND COMMUNITY ENGAGEMENT UNITED STATES FUND FOR UNICEF

Public Safety and Health Cooperation from the Canadian Perspective

TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE

Health Task Force Workplan

FAO of the UN, WHO and OIE with the collaboration of UNSIC and UNICEF. Background Paper

Joint Statement of The Tenth China-Japan-Korea Tripartite Health Ministers' Meeting (THMM)

CDC s Global Disease Detection Program

GAVI, THE VACCINE ALLIANCE

Global Health Policy: Vaccines

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

Expanded Programme on Immunization

Promotion of Regulatory Cooperation Perspectives from the International Regulatory Cooperation for Herbal Medicines (IRCH)

5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)

Overview OIE/JTF project on HPAI control in Asia and other related programs by the OIE Asia-Pacific

Prevention and Control of Communicable Diseases at the Airport Hong Kong Experience

Pandemic Influenza Preparedness and Response

APEC Ministerial Meeting on Avian and Influenza Pandemics Da Nang, Viet Nam, 4-6 May 2006

Contribution of avian influenza data through OFFLU network

Viet Nam Avian Influenza Control and Preparedness

GAVI, THE VACCINE ALLIANCE

Situation and Strategies on HPAI Prevention and Control in China

Avian Influenza Intersectoral Collaboration

Influenza Pandemic Preparedness for Clinicians on the Frontline

Industry Perspective: Strategies and costs associated with increasing seasonal influenza vaccine. since 2006

WHO HHS Workshop on Business Modeling for Sustainable Influenza Vaccine Manufacturing

Access to vaccination in GAVI countries and at global level

ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS

International PolioPlus Committee PolioPlus Facts and Figures June Rotary s financial contribution to the polio eradication effort:

AVIAN INFLUENZA. USAID Strategy

For information on programmes in other countries and regions please access the Federation website at Programme title 2005

IHR News. The WHO quarterly bulletin on IHR implementation. 30 June 2009, No. 7

Feasibility of Production of Human AI Vaccine in AI vaccine Manufacturers in China. Gu Hong Ministry of Agriculture of P. R. China

Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012

Global Governance for Health: Protecting Vulnerable People from Infectious Diseases in Countries with Weak Health System

All About Vaccines and How They Get to Those Who Need Them Most. Elesha Kingshott

Expanded Programme on Immunization

Egypt Success Story In Combating Avian Influenza

Preventing disease Promoting and protecting health

INDONESIA S RESPONSE TO AVIAN INVLUENZA (October 7, 2005) A. Assessment of Key Areas of the Country s Overall Preparedness

Mika Shimizu, Ph.D. Visiting Scholar, East West Center & Abe Fellow

FY12 FY14 Strategic Plan

JOINT STATEMENT OF ASEAN PLUS THREE HEALTH MINISTERS SPECIAL MEETING ON EBOLA PREPAREDNESS AND RESPONSE Bangkok, Thailand, 15 December 2014

Saving lives through immunisation A Corporate Social Responsibility approach

IHR and Asia Pacific Strategy for Emerging Diseases. Health Security and Emergencies (DSE) WHO Western Pacific Regional Office (WPRO)

RUSSIA Mobilizing support for the Global Fund to Fight AIDS, Tuberculosis, and Malaria

WHO priorities for 2016 in US PICTs

Perspective from ASEAN: WHO support activities. Health and Communicable Disease Division, ASEAN Secretariat

Immunization Financing Outlook: A Historical Perspective

Highly Pathogenic Avian Influenza Worldwide situation Larnaca, Cyprus, July 2009

Pandemic Influenza: U.S. Government Perspective on International Issues

IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION. GAVI Board - 13 June 2017, Geneva

VACCINE MARKETS OVERVIEW SESSION

Strong Political Commitment and Speed of Action - Key to Success in SARS Containment in Vietnam

Michel BAIJOT Vice President, WW Business Development & Strategic Alliances

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

PRESS RELEASE. Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between

1. Avian Influenza H5N1 had not occurred in Malaysia until the first case of

Linking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning

Report to the Board 6-7 June 2018

The OIE World Animal Health and Welfare Fund

The Prime Minister s Challenge on Dementia & 2013, G8 Dementia Legacy Making it Happen

Approaches to Pandemic Influenza Vaccine Preparedness

USAID s approach to the control of avian and pandemic influenza

PAEDIATRIC ASSOCIATION OF NIGERIA & CONTRIBUTIONS TO IMMUNIZATIONS IN NIGERIA

Regional Prospective of Vaccine Procurement in SEE Countries

UNICEF s Response to the Ebola Crisis. Presenta(on to the Execu(ve Board, Informal Session, 11 September 2014

Pandemic Preparedness Communications: WHO

Whole Of Society Approach To Preparedness

Countries initially targeted: Bangladesh, Mongolia, Myanmar, Nepal, Lao People s Demoncratic Republic and Pakistan.

Avian Influenza A(H7N9) Overview

Innovative Finance: the power of innovation to save lives

7th Mena Influenza Stakeholders Meeting. WHO Influenza Strategy Development and Vaccine-related Research Priorities

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,

Appendix 3: Federal Government Agencies Involved in Immunization

One Health and Capacity Assessments

National Strategies for Controlling Avian Influenza Viruses

Epidemiology Treatment and control Sniffles and Sneezes Mortality Spanish flu Asian flu Hong Kong flu The Swine flu scare

Review of Vaccine and Vaccination Component in Global Avian Influenza Control Strategies

University of Colorado Denver. Pandemic Preparedness and Response Plan. April 30, 2009

Report to the GAVI Alliance Board 7-8 July 2011

International Coordinating Group for vaccine provision. Emergency Vaccine Stockpiles

Global Partners' Group

Towards a Sustainable Global Infrastructure for Medical Countermeasures

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

Global Challenges of Pandemic and Avian Influenza. 19 December 2006 Keiji Fukuda Global influenza Programme

Mekong Basin Disease Surveillance (MBDS) Network

Task Force on Immunization (TFI) in Africa 14 th Annual Meeting. And. Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting

USAID Progress: The U.S. National Vaccine Plan of 1994

REVIEW OF DECISIONS. BOARD MEETING 6-7 June 2018, Geneva. Reach every child

Measles and Rubella Initiative Outbreak Response Fund Standard Operating Procedures, effective 01 April 2017

Gavi s private sector engagement approach

Vaccines: Poised To Deliver Significant Growth in Emerging Markets

Progress with IPV introduction Polio Partners Group PPG 16 June 2014

Global Health Security: Preparedness and Response: can we do better and stay safe?

New Delhi International Ministerial Conference on Avian and Pandemic Influenza Dec 4-6th, 2007

1. The World Bank-GAVI Partnership and the Purpose of the Review

Transcription:

China MOH and Sanofi Pasteur Collaborations in Pandemic Preparedness Presented by

General overview of Sanofi Pasteur Our Vision A world in which no one suffers or dies from a vaccine preventable disease Our Mission To protect and improve human health worldwide by providing superior, innovative vaccines for the prevention and treatment of disease and by playing an active role in the immunization community to maximize vaccination

Our Global Commitment to Improve Access to Vaccines Global Polio Eradication Initiative Some 2 billion children immunized since 1988 The largest corporate donor with 120 million doses of polio vaccine GAVI (Global Alliance for Vaccines and Immunization) In 5 years, 99 million more children received new vaccines, 15 million more received basic vaccines EPIVAC Training program for African doctors to increase and improve immunization campaigns Since 2002, 250 doctors trained in 8 Central and West African countries Partnerships with a number of Non-Governmental Organizations and International Institutions, including WHO, UNICEF, PAHO, International Red Cross, Rotary International, etc. More than 500 million doses of vaccines were delivered in 2006

China in Focus: China MOH and Sanofi Pasteur collaborations in pandemic preparedness Cooperative International symposiums on Prevention and Control of HPAI and Influenza Pandemic. Annual cooperation between China MOH and Sanofi Pasteur Held three times from 2005 to 2007 Planning the symposium of 2008 Facilitate the talent exchange program between the Public Health organizations of the two countries. Facilitate Non-Governmental Organizations to pay site visits to China, including WHO, APACI, etc.

Cooperation of the International Symposium on Prevention and Control of HPAI and Influenza Pandemic Disease prevention and control received unprecedented level of concern in China since the outbreak of SARS and avian influenza. The cooperation program aims to provide a platform for HPAI and Influenza experts as well as government officials worldwide to exchange up-to-date information and prevention strategies towards HPAI and Influenza Pandemic. Annual cooperation between China MOH and Sanofi Pasteur from 2005-2007: October 2005, Mr. Wang Longde, Former Vice Minister of Health, present at the meeting and gives a speech. September 2007, Mr. Chen Zhu, Minister of Health, present at the meeting and gives an opening speech. Over 100 participants attend the Symposium each year, including WHO representatives in China, officials from China MOH, SFDA, MOA, National CDC, BOF, AQSIQ, representatives from Hong Kong and Macau Public Health Department, vaccine experts from Sanofi Pasteur and Pasteur Institute, and representatives from China provincial BOH and CDC.

Cooperation of the International Symposium on Prevention and Control of HPAI and Influenza Pandemic, October 2005 6

Cooperation of the International Symposium on Prevention and Control of HPAI and Influenza Pandemic, August 2006 7

Cooperation of the International Symposium on Prevention and Control of HPAI and Influenza Pandemic, September 2007

Cooperation of the International Symposium on Prevention and Control of HPAI and Influenza Pandemic, September 2007

Conclusion Incentives for collaboration Company social responsibility To exchage the up-to-date information and technology for better Pandemic Influenza Preparedness To facilitate the experts intercommunication worldwide To deepen the mutual understanding of the risks and potential impacts of Pandemic Influenza Challenges to collaboration To continue the collaboration strategically in order to improve the public awareness of Pandemic Influenza To enhance the collaboration within the extent of Pandemic Influenza Preparedness